Page last updated: 2024-11-04

risedronic acid and Spinal Neoplasms

risedronic acid has been researched along with Spinal Neoplasms in 1 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Spinal Neoplasms: New abnormal growth of tissue in the SPINE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tripto-Shkolnik, L1
Rouach, V1

Other Studies

1 other study available for risedronic acid and Spinal Neoplasms

ArticleYear
A dramatic increase in bone mineral density, enhanced osteoblast activity and malignancy.
    QJM : monthly journal of the Association of Physicians, 2020, Apr-01, Volume: 113, Issue:4

    Topics: Absorptiometry, Photon; Aged, 80 and over; Bone Density; Humans; Lumbar Vertebrae; Male; Osteoblasts

2020